| Title | Transatlantic Divide: How U.S. Pays Three Times More for Drugs | |
| Date | Thursday October 15 2015, @01:03PM | |
| Author | janrinok | |
| Topic | ||
| from the money-makes-the-world-go-round dept. | ||
U.S. prices for the world's 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters.
The finding underscores a transatlantic gulf between the price of treatments for a range of diseases and follows demands for lower drug costs in America from industry critics such as Democratic presidential candidate Hillary Clinton.
The 20 medicines, which together accounted for 15 percent of global pharmaceuticals spending in 2014, are a major source of profits for companies including AbbVie (ABBV.N), AstraZeneca (AZN.L), Merck (MRK.N), Pfizer (PFE.N) and Roche (ROG.VX).
| Links |
printed from SoylentNews, Transatlantic Divide: How U.S. Pays Three Times More for Drugs on 2026-10-08 07:59:17